Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.
D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D002908:Chronic Disease; D006505:Hepatitis / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008099:Liver / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
D000906:Antibodies; D000974:Antibodies, Antinuclear; D001798:Blood Proteins; D006511:Hepatitis B Antigens; D007136:Immunoglobulins; D001379:Azathioprine; D011241:Prednisone